Keywords
Dialysis Access
Post-COVID Healthcare
Barriers to Treatment
Categories
How to Cite
Abstract
Chronic Kidney Disease (CKD) is a major and rising public health issue in India that affects almost 17% of the adult population. The recent treatment issues with CKD patients in India from 2023 to 2025 are investigated in this paper based on the results of a number of recent studies. The five important challenges are recognized to be: restricted access to early diagnosis and nephrology treatment, low affordability of transplant and dialysis treatment, fragmentation between public and private sectors, poor mental health and nutritional treatment, and post-COVID-19 systemic disruptions.
Despite programs such as the Pradhan Mantri National Dialysis Program and Ayushman Bharat, knowledge and implementation gaps, especially among rural and deprived populations, prevail. Out-of-pocket costs, long travel to reach treatment sites, substandard trained staff, and unpredictable frequencies of dialysis are endured by patients. There is social stigma, lack of awareness of CKD, and inadequate incorporation of mental health or dietary counseling within care as well. The article also highlights the economic and psychological cost of the treatment disruption during and after the COVID-19 pandemic.
This paper integrates current policy reviews, epidemiological data, and clinical practice with a qualitative synthesis approach. Suggested interventions include the development of nephrology facilities, initiation of national screening, insurance reform, and the inclusion of holistic, patient-focused care models. Without an imminent multisectoral intervention, the CKD burden in India will rise, worsening morbidity and increasing health disparities.
References
1. Essue, B., Jha, V., John, O., Knight, J., & Jan, S. (2018). Universal health coverage and chronic kidney disease in India. Bulletin of the World Health Organization, 96, 442 - 442. https://doi.org/10.2471/BLT.18.208207.
2. Wijewickrama, E., Alam, M., Bajpai, D., et.al (2024). Capacity for managing kidney failure in the International Society of Nephrology South Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).. Kidney international supplements, 13 1, 123-135 . https://doi.org/10.1016/j.kisu.2024.01.007.
3. Jha, V. (2013). Current status of end-stage renal disease care in India and Pakistan. Kidney International, 3, 157-160. https://doi.org/10.1038/KISUP.2013.3.
4. Rahaman, S., Sarkar, N., Taher, M., Pandey, A., Bank, S., Banerjee, A., & Biswas, T. (2024). STANDARD AYURVEDIC MANAGEMENT FOR CHRONIC KIDNEY DISEASE. Science and Culture. https://doi.org/10.36094/sc.v89.2024.standard_ayurvedic_management_for_chronic.rahaman.203.
5. Varughese, S., & Abraham, G. (2018). Chronic Kidney Disease in India: A Clarion Call for Change.. Clinical journal of the American Society of Nephrology : CJASN, 13 5, 802-804 . https://doi.org/10.2215/CJN.09180817.
6. Bharati, J., & Jha, V. (2020). Global Dialysis Perspective: India.. Kidney360, 1 10, 1143-1147 . https://doi.org/10.34067/kid.0003982020.
7. Maity, I., Sati, H., Singh, G., Bhowmik, D., Agarwal, S., & Bagchi, S. (2024). The burden of chronic kidney disease of undetermined etiology (CKDu) in a tertiary care public hospital in north India.. Nephron. https://doi.org/10.1159/000539317.
8. Singh, A., Farag, Y., Mittal, B., et.al. (2013). Epidemiology and risk factors of chronic kidney disease in India – results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrology, 14, 114 - 114. https://doi.org/10.1186/1471-2369-14-114.
9. Prasad, N., Hatt, M., Agarwal, S., et.al. (2020). The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in India. Kidney International Reports, 5, 1545 - 1550. https://doi.org/10.1016/j.ekir.2020.06.034.
10. Bawaskar, P., Bawaskar, P., & Bawaskar, H. (2015). Eliminating acute kidney injury by 2025: an achievable goal for India. The Lancet, 386. https://doi.org/10.1016/S0140-6736(15)00014-8.
11. Anand, S., Anand, S., Shivashankar, R., Ali, M., et.al (2015). Prevalence of chronic kidney disease in two major Indian cities and projections for associated cardiovascular disease. Kidney international, 88, 178 - 185. https://doi.org/10.1038/ki.2015.58.
12. Theodorakopoulou, M., Ortiz, A., Fernandez-Fernandez, B., Kanbay, M., Minutolo, R., & Sarafidis, P. (2024). Guidelines for the management of hypertension in CKD patients: where do we stand in 2024?. Clinical Kidney Journal, 17, ii36 - ii50. https://doi.org/10.1093/ckj/sfae278.
13. Talukdar, R., Ajayan, R., Gupta, S., Biswas, S., Parveen, M., Sadhukhan, D., Sinha, A., & Parameswaran, S. (2025). Chronic Kidney Disease Prevalence in India: A Systematic Review and Meta-Analysis From Community-Based Representative Evidence Between 2011 to 2023.. Nephrology, 30 1, e14420 . https://doi.org/10.1111/nep.14420.
14. B, N., & Darwin, R. (2023). To Evaluate the Epidemiology, Etiology, Risk Factors and Treatment Management in Chronic Kidney Disease in Children, Adult and Geriatric Patients in a Tertiary Care Teaching Hospital in Nellore. INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE. https://doi.org/10.25258/ijpqa.14.4.30.
15. Rudang, S., Rambe, R., & Annisa, S. (2024). Identifikasi Drug Related Problems Pada Pasien Penyakit Ginjal Kronis Di Rumah Sakit Prof. dr. Chairuddin Panusunan Lubis Tahun 2023. Indonesian Journal of Pharmaceutical and Clinical Research. https://doi.org/10.32734/idjpcr.v7i1.18031.
16. Agarwal, S., & Srivastava, R. (2009). Chronic Kidney Disease in India: Challenges and Solutions. Nephron Clinical Practice, 111, c197 - c203. https://doi.org/10.1159/000199460.
17. Agarwal, S. (2005). Chronic kidney disease and its prevention in India.. Kidney international. Supplement, 98, S41-5 . https://doi.org/10.1111/J.1523-1755.2005.09808.X.
18. Ji, A., Chaudhary, G., Singh, M., & , R. (2024). Integrating Ayurveda in Chronic Kidney Disease Management. AYUSHDHARA. https://doi.org/10.47070/ayushdhara.v11i5.1765.
19. Buosi, A., Paturkar, D., Dias, E., Estorninho, M., Kolawole, O., Ghooi, R., & Lutchman, S. (2021). The Rights of Patients with Chronic Kidney Disease in the World: Legal Perspectives and Challenges in Brazil, India, Portugal, South Africa, and Nigeria.. Contributions to nephrology, 199, 1-17 . https://doi.org/10.1159/000517722.
20. Hussain, S., Habib, A., & Najmi, A. (2019). Limited Knowledge of Chronic Kidney Disease among Type 2 Diabetes Mellitus Patients in India. International Journal of Environmental Research and Public Health, 16. https://doi.org/10.3390/ijerph16081443.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 South India Journal of Social Sciences